1. Home
  2. INBS vs CLGN Comparison

INBS vs CLGN Comparison

Compare INBS & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

INBS

Intelligent Bio Solutions Inc.

HOLD

Current Price

$2.31

Market Cap

5.7M

Sector

Health Care

ML Signal

HOLD

Logo CollPlant Biotechnologies Ltd

CLGN

CollPlant Biotechnologies Ltd

HOLD

Current Price

$0.34

Market Cap

6.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INBS
CLGN
Founded
2016
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical Specialities
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7M
6.0M
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
INBS
CLGN
Price
$2.31
$0.34
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$11.00
AVG Volume (30 Days)
71.5K
78.4K
Earning Date
05-08-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
68.65
N/A
EPS
N/A
N/A
Revenue
$1,980,484.00
N/A
Revenue This Year
$778.48
$240.45
Revenue Next Year
N/A
$38.03
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.54
$0.27
52 Week High
$24.90
$3.23

Technical Indicators

Market Signals
Indicator
INBS
CLGN
Relative Strength Index (RSI) 38.81 33.11
Support Level $2.27 $0.27
Resistance Level $3.16 $0.45
Average True Range (ATR) 0.14 0.04
MACD -0.01 -0.00
Stochastic Oscillator 12.82 22.29

Price Performance

Historical Comparison
INBS
CLGN

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.

Share on Social Networks: